Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CSF3R |
| Variant | W341C |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | CSF3R W341C lies within fibronectin type-III domain 3 of the Csf3r protein (UniProt.org). W341C confers a gain of function to the Csf3r protein as demonstrated by increased receptor dimerization, elevated Stat5, Jak2 and Erk activation, and transformation in cultured cells (PMID: 28652245). |
| Associated Drug Resistance | |
| Category Variants Paths |
CSF3R mutant CSF3R act mut CSF3R W341C |
| Transcript | NM_000760.4 |
| gDNA | chr1:g.36472114C>A |
| cDNA | c.1023G>T |
| Protein | p.W341C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_156039 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_172313 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_000760 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_017000370 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_011540748.3 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_005270493.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_011540749.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_156039.3 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_005270493.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_017000370.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_011540748 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_172313.2 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_047446753.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_011540749 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_005270493 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| XM_011540749.1 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_172313.3 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_000760.3 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_000760.4 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| NM_156039.3 | chr1:g.36472114C>A | c.1023G>T | p.W341C | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| CSF3R W341C | hematologic cancer | sensitive | Ruxolitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Jakafi (ruxolitinib) inhibited viability of a cell line expressing CSF3R W341C in culture (PMID: 28652245). | 28652245 |